Whipple's disease medical therapy: Difference between revisions
Jump to navigation
Jump to search
Line 10: | Line 10: | ||
==== Classic Whipple's disease ==== | ==== Classic Whipple's disease ==== | ||
*Initial therapy | |||
**Preferred regimen (1): [[Ceftriaxone]] 2 g IV qd for 14 days | |||
**Preferred regimen (2): Penicillin G 2 million units IV q4h for 14 days | |||
**Alternative regimen (1): [[Meropenem]] 1 g IV q8h for 14 days | |||
*Maintenance therapy | |||
**Preferred regimen (1): | |||
**Alternative regimen (1): | |||
==== CNS infection ==== | ==== CNS infection ==== | ||
*Initial therapy | |||
**Preferred regimen (1): [[Ceftriaxone]] 2 g IV qd for 14 days | |||
**Preferred regimen (2): Penicillin G 2 million units IV q4h for 14 days | |||
**Alternative regimen (1): [[Meropenem]] 1 g IV q8h for 14 days | |||
*Maintenance therapy | |||
**Preferred regimen (1): | |||
**Alternative regimen (1): | |||
==== Endocarditis ==== | ==== Endocarditis ==== | ||
*Initial therapy | |||
**Preferred regimen (1): [[Ceftriaxone]] 2 g IV qd for 14 days | |||
**Preferred regimen (2): Penicillin G 2 million units IV q4h for 14 days | |||
**Alternative regimen (1): [[Meropenem]] 1 g IV q8h for 14 days | |||
*Maintenance therapy | |||
**Preferred regimen (1): | |||
**Alternative regimen (1): | |||
==== Relapse ==== | ==== Relapse ==== | ||
*Initial therapy | |||
**Preferred regimen (1): [[Ceftriaxone]] 2 g IV qd for 14 days | |||
**Preferred regimen (2): Penicillin G 2 million units IV q4h for 14 days | |||
**Alternative regimen (1): [[Meropenem]] 1 g IV q8h for 14 days | |||
*Maintenance therapy | |||
**Preferred regimen (1): | |||
**Alternative regimen (1): | |||
Revision as of 21:07, 2 November 2017
Whipple's disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Whipple's disease medical therapy On the Web |
American Roentgen Ray Society Images of Whipple's disease medical therapy |
Risk calculators and risk factors for Whipple's disease medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
The mainstay of treatment for Whipple's disease is systemic long-term antibiotic therapy. Pharmacologic medical therapies for [disease name] include (either) [therapy 1], [therapy 2], and/or [therapy 3].
Medical Therapy
- Pharmacologic medical therapy for Whipple's disease includes long-term antibiotics.
Classic Whipple's disease
- Initial therapy
- Preferred regimen (1): Ceftriaxone 2 g IV qd for 14 days
- Preferred regimen (2): Penicillin G 2 million units IV q4h for 14 days
- Alternative regimen (1): Meropenem 1 g IV q8h for 14 days
- Maintenance therapy
- Preferred regimen (1):
- Alternative regimen (1):
CNS infection
- Initial therapy
- Preferred regimen (1): Ceftriaxone 2 g IV qd for 14 days
- Preferred regimen (2): Penicillin G 2 million units IV q4h for 14 days
- Alternative regimen (1): Meropenem 1 g IV q8h for 14 days
- Maintenance therapy
- Preferred regimen (1):
- Alternative regimen (1):
Endocarditis
- Initial therapy
- Preferred regimen (1): Ceftriaxone 2 g IV qd for 14 days
- Preferred regimen (2): Penicillin G 2 million units IV q4h for 14 days
- Alternative regimen (1): Meropenem 1 g IV q8h for 14 days
- Maintenance therapy
- Preferred regimen (1):
- Alternative regimen (1):
Relapse
- Initial therapy
- Preferred regimen (1): Ceftriaxone 2 g IV qd for 14 days
- Preferred regimen (2): Penicillin G 2 million units IV q4h for 14 days
- Alternative regimen (1): Meropenem 1 g IV q8h for 14 days
- Maintenance therapy
- Preferred regimen (1):
- Alternative regimen (1):
- 1. Initial Parenteral Therapy[1]
- Preferred regimen: Ceftriaxone 2 g IV daily for 2 weeks
- 2. Long-term Therapy[2]
- Preferred regimen: Trimethoprim-sulfamethoxazole 160/800 mg PO bid for at least 1 year
- Alternative regimen: Doxycycline 100 mg PO bid AND
References
- ↑ Bennett, John (2015). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1455748013.
- ↑ Bennett, John (2015). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1455748013.